Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marc G. J. Feuilloley has a total of 522 co-authors. Here are the top co-authors by number of shared publications:

  • Sylvie Chevalier

    Univ Rouen Normandie, Université Caen Normandie, Normandie Univ, CBSA, France

    48 shared publications
  • Nicole Orange

    Laboratoire de Microbiologie Signaux et Microenvironnement (LMSM) EA 4312, Normandie Université, Université de Rouen Normandie, Centre de Sécurité Sanitaire de Normandie, Evreux, France

    27 shared publications
  • Olivier Maillot

    Unité de recherche Communication Bactérienne et Stratégies Anti-infectieuses, CBSA UR4312, Université de Rouen Normandie, Normandie Université, Evreux, France

    25 shared publications
  • Nathalie Connil

    CBSA UR 4312, Univ Rouen Normandie, Normandy Univ

    21 shared publications
  • Olivier Lesouhaitier

    Unité de recherche Communication Bactérienne et Stratégies Anti-infectieuses, CBSA UR4312, Université de Rouen Normandie, Normandie Université, Evreux, France

    20 shared publications
  • Alain Dufour

    Laboratoire de Biotechnologie et Chimie Marines, Université Bretagne Sud, EMR CNRS 6076, IUEM, 56100 Lorient, France

    17 shared publications

Latest Publications

  • Open Access

    Airborne bacteria Pseudomonas fluorescens MFAF76a and TiO2 and ZnO nanoparticles interactions in the respiratory epithelial barrier: insights from an air-liquid interface (ALI) co-exposure model

    by Victoire Bohuon, Hung LE, Madalina Ababii, Benoit Bernay, Julien Pontin, Alexandre Jouvin, Isabelle Lopes, Sandra Leblanc, Marc Feuilloley, Cécile Duclairoir Poc

    Nanoparticles (NPs) are used in various industries due to their unique physicochemical properties. The increasing use of metal-oxide NPs such as titanium dioxide (TiO2) and zinc oxide (ZnO) raises concerns regarding their impact on the respiratory tract, particularly in the presence of environmental microorganisms. Their interplay on epithelial tissue may reciprocally influence their translocation.,Impacts of TiO2 and ZnO NPs on the environmental bacterium Pseudomonas fluorescens MFAF76a were investigated, as well as their interaction with in vitro human epithelial models. First, biotic NPs impacts were examined, then the tripartite ones.,Physiological and proteomic responses of P. fluorescens to TiO2 and ZnO NP exposure were characterised through membrane integrity assays, morphological analysis and proteomic profiling. Bacterial and NP translocation across the respiratory epithelial barrier was assessed using an A549 air–liquid interface model, with elemental quantification performed by ICP-MS.,ZnO NPs induced more pronounced effects on bacterial physiology than TiO2 NPs, including alterations in envelope integrity and morphology, with proteomic modulations related to envelope remodelling, detoxification and DNA repair. Both bacteria and NPs were detected in basal compartment, demonstrating their ability to cross the epithelial barrier without inducing significant cytotoxicity. Distinct translocation profiles were observed. ZnO NPs likely crossed the barrier through ionic dissolution into Zn²⁺, whereas TiO2 NPs formed aggregates with sedimentation and were internalised by epithelial cells without crossing them.,This study highlights that metal-oxide NPs, particularly ZnO NPs, can disrupt cell envelope functions and trigger stress response mechanisms in bacteria. However, their presence does not affect bacterial translocation.

  • Open Access

    Plants Versus Human Skin Microbiota, a Bioinspired Analysis

    by Marc G.J. Feuilloley, Stéphane Desaint, Cécile L’Haridon, Véronique Schwartz-Boishu, Groupe Rocher Scientific Advisory Board

    Human and plants microbiota are different but they also show common specificities, such as regional distribution and a huge diversity of bacteria, fungi, yeasts, viruses, archaea, and even viroids. The plants surface, or phyllosphere commensal microbial population contains a significant number of microbial species with are also present in the human cutaneous microbiota and several of those bacteria have activities in plants that are also of interest for the human skin. Plants also harbor an abundant intra-tissular or endophyte microbiota, suggesting that some vegetal active compounds should be in fact of microbial origin suggesting potential new strategies for the production of active cosmetic and pharmaceutical ingredients. The plant microbiota is at the origin of soluble, but also volatile molecules and exosomes that confer protection against environmental stresses and their activities in now considered for transposition to cosmetic products. Despite the plant phyllosphere is essentially composed of Gram-negative bacterial species while the majority of skin associated bacteria are Gram-positive, they interact following same strategies and, in both cases, communicate with their eucaryotic host through hormones, mimetics compounds and cytokines. Then technics used in phytoremediation could be also applied to preserve skin microbiota homeostasis and skin integrity. In the present review, we investigate the complexity of the plant microbiota in regard of the human counterpart , targeting to establish parallels between microorganisms, molecules and strategies that can be applied in cosmetology and pharmacology.

  • Open Access

    Microbiome Modulation in Acne Patients and Clinical Correlations

    by Marius-Anton Ionescu, Alin Laurentiu Tatu, Camelia Busila, Elena Roxana Axente, Nelly Badalato, Marc G. J. Feuilloley, Estelle Asquier, José Dario Martínez, Luc Lefeuvre

    Background: The imbalance of skin microbiota in acne can induce changes leading to induction or to aggravation of chronic inflammatory lesions; complex mechanisms are involved. Cutibacterium acnes (C. acnes) ribotypes RT4 and RT5 express more biofilm and are associated with inflammatory acne lesions. C. acnes RT6 is a non-acne ribotype, beneficial for the skin. Objectives: In an open clinical trial, acne adults were included and assessed clinically at baseline and at month 2 using the Investigator Global Assessment of Acne (IGA) score. A topical emulsion was applied twice daily for 2 months (M2) in each included patient. In the same series of acne patients, skin swab samples were collected from acne patients at baseline and M2 from lesional and non-lesional skin; skin swabs were collected for the metagenomic long-read analysis of microbiota. Materials and Methods: Acne patients with a gravity score IGA of >1Umbelliferae associated with a polysaccharide at 1% was applied twice daily for 2 months. At baseline and M2 clinical assessments were made; skin swab samples were also taken for microbiota analysis from lesional and non-lesional skin in each included patient. Extractions of genomic DNA (gDNA) from swab samples from baseline and from M2 were made, followed by full-length (V1–V9) amplification of the 16S rDNA and sequencing of amplicon libraries for strain-level bacterial community profiling. Results: In a series of 32 adult acne patients, the mean initial IGA scale was 3.1; at M2 the IGA scale was 1.5 (p < 0.001). The mean decrease in acne lesions was by 63%. Microbiome metagenomic long-read analysis in these series was mainly dominated by C. acnes followed by Staphylococcus epidermidis (S. epidermidis). The density of C. acnes ribotypes RT6 (non-acne strain) was increased at M2 compared to baseline and the density of ribotypes C. acnes RT1 to RT5 was decreased at M2, compared to baseline (p < 0.0001). S. epidermidis ribotypes (1 to 36) were non significantly increased at M2, compared to baseline (p < 0.1). Conclusions: In a series of 32 acne patients that applied an emulsion based on vegetal extract of Umbelliferae and a polysaccharide at 1% twice daily, a significant clinical improvement in IGA scale for acne lesions was seen at M2, compared to baseline (p < 0.0001). The clinical improvement was correlated with an improvement in skin microbiome at M2 compared to baseline, indicated by the increase in the relative abundance of non-acne strain of C. acnes ribotype 6 and of the decrease in the relative abundance of acne strains ribotypes C. acnes RT1 to RT5.


  • Open Access

    Membrane fluidity homeostasis is required for tobramycin-enhanced biofilm in Pseudomonas aeruginosa

    by Audrey David, Ali Tahrioui, Rachel Duchesne, Anne-Sophie Tareau, Olivier Maillot, Magalie Barreau, Marc G. J. Feuilloley, Olivier Lesouhaitier, Pierre Cornelis, Emeline Bouffartigues, et al.

    Pseudomonas aeruginosa is an opportunistic pathogen, which causes chronic infections, especially in cystic fibrosis (CF) patients where it colonizes the lungs via the build-up of biofilms. Tobramycin, an aminoglycoside, is often used to treat P. aeruginosa infections in CF patients. Tobramycin at sub-minimal inhibitory concentrations enhances both biofilm biomass and thickness in vitro ; however, the mechanism(s) involved are still unknown. Herein, we show that tobramycin increases the expression and activity of SigX, an extracytoplasmic sigma factor known to be involved in the biosynthesis of membrane lipids and membrane fluidity homeostasis. The biofilm enhancement by tobramycin is not observed in a sigX mutant, and the sigX mutant displays increased membrane stiffness. Remarkably, the addition of polysorbate 80 increases membrane fluidity of sigX -mutant cells in biofilm, restoring the tobramycin-enhanced biofilm formation. Our results suggest the involvement of membrane fluidity homeostasis in biofilm development upon tobramycin exposure. IMPORTANCE: Previous studies have shown that sub-lethal concentrations of tobramycin led to an increase biofilm formation in the case of infections with the opportunistic pathogen Pseudomonas aeruginosa . We show that the mechanism involved in this phenotype relies on the cell envelope stress response, triggered by the extracytoplasmic sigma factor SigX. This phenotype was abolished in a sigX -mutant strain. Remarkably, we show that increasing the membrane fluidity of the mutant strain is sufficient to restore the effect of tobramycin. Altogether, our data suggest the involvement of membrane fluidity homeostasis in biofilm development upon tobramycin exposure.


  • Open Access

    “Beneficial Microbes: Food, Mood and Beyond”—Editorial and the Perspectives of Research

    by Mohamed Zommiti, Mounir Ferchichi, Marc G. J. Feuilloley

    Amongst the list of beneficial microbes, lactic acid bacteria (LAB), Bifidobacterium sp


  • Open Access

    Organs-on-Chips Platforms Are Everywhere: A Zoom on Biomedical Investigation

    by Mohamed Zommiti, Nathalie Connil, Ali Tahrioui, Anne Groboillot, Corinne Barbey, Yoan Konto-Ghiorghi, Olivier Lesouhaitier, Sylvie Chevalier, Marc G. J. Feuilloley

    Over the decades, conventional in vitro culture systems and animal models have been used to study physiology, nutrient or drug metabolisms including mechanical and physiopathological aspects. However, there is an urgent need for Integrated Testing Strategies (ITS) and more sophisticated platforms and devices to approach the real complexity of human physiology and provide reliable extrapolations for clinical investigations and personalized medicine. Organ-on-a-chip (OOC), also known as a microphysiological system, is a state-of-the-art microfluidic cell culture technology that sums up cells or tissue-to-tissue interfaces, fluid flows, mechanical cues, and organ-level physiology, and it has been developed to fill the gap between in vitro experimental models and human pathophysiology. The wide range of OOC platforms involves the miniaturization of cell culture systems and enables a variety of novel experimental techniques. These range from modeling the independent effects of biophysical forces on cells to screening novel drugs in multi-organ microphysiological systems, all within microscale devices. As in living biosystems, the development of vascular structure is the salient feature common to almost all organ-on-a-chip platforms. Herein, we provide a snapshot of this fast-evolving sophisticated technology. We will review cutting-edge developments and advances in the OOC realm, discussing current applications in the biomedical field with a detailed description of how this technology has enabled the reconstruction of complex multi-scale and multifunctional matrices and platforms (at the cellular and tissular levels) leading to an acute understanding of the physiopathological features of human ailments and infections in vitro.


  • Open Access

    Pf4 Phage Variant Infection Reduces Virulence-Associated Traits in Pseudomonas aeruginosa

    by Damien Tortuel, Ali Tahrioui, Audrey David, Mélyssa Cambronel, Flore Nilly, Thomas Clamens, Olivier Maillot, Magalie Barreau, Marc G. J. Feuilloley, Olivier Lesouhaitier, et al.

    Filamentous bacteriophages can become superinfective and infect P. aeruginosa , even though they are inserted in the genome as lysogens. Despite this productive infection, growth of the host is only mildly affected, allowing the study of the interaction between the phage and the host, which is not possible in the case of lytic phages killing rapidly their host.


  • Open Access

    Effect of Phthalates and Their Substitutes on the Physiology of Pseudomonas aeruginosa

    by Mélissande Louis, Ali Tahrioui, Julien Verdon, Audrey David, Sophie Rodrigues, Magalie Barreau, Maëliss Manac’h, Audrey Thiroux, Baptiste Luton, Charly Dupont, et al.

    Phthalates are used in a variety of applications—for example, as plasticizers in polyvinylchloride products to improve their flexibility—and can be easily released into the environment. In addition to being major persistent organic environmental pollutants, some phthalates are responsible for the carcinogenicity, teratogenicity, and endocrine disruption that are notably affecting steroidogenesis in mammals. Numerous studies have thus focused on deciphering their effects on mammals and eukaryotic cells. While multicellular organisms such as humans are known to display various microbiota, including all of the microorganisms that may be commensal, symbiotic, or pathogenic, few studies have aimed at investigating the relationships between phthalates and bacteria, notably regarding their effects on opportunistic pathogens and the severity of the associated pathologies. Herein, the effects of phthalates and their substitutes were investigated on the human pathogen, Pseudomonas aeruginosa, in terms of physiology, virulence, susceptibility to antibiotics, and ability to form biofilms. We show in particular that most of these compounds increased biofilm formation, while some of them enhanced the bacterial membrane fluidity and altered the bacterial morphology.


  • Open Access

    Effects of Verapamil and Two Bisbenzylisoquinolines, Curine and Guattegaumerine Extracted from Isolona hexaloba, on the Inhibition of ABC Transporters from Pseudomonas aeruginosa

    by Christian Hulen, Pierre-Jean Racine, Marc Feuilloley, Abdelhakim Elomri, Nour-Eddine Lomri

    The biological effects of alkaloids, curine, guattegaumerine, and verapamil, on Pseudomonas aeruginosa were investigated. These molecules did not inhibit P. aeruginosa growth but increased the sensitivity of this bacterium to carbenicillin, novobiocin, and erythromycin. The results of another study indicate that curine and guattegaumerine were competitors of verapamil and acted as inhibitors of eukaryotic ABCB1 efflux pump. A BLAST-P carried out between a bacterial MDR transporter LmrA from Lactococcus lactis, a human MDR1/P-glycoprotein (ABCB1), and ABC proteins of P.aeruginosa highlighted five potential candidates that have this bacterium. A study on the sensitivity to carbenicillin in the presence of verapamil allowed us to identify the product of gene PA1113 as the ABC transporter involved in the influx of carbenicillin. Similarly, novobiocin transport performed in the presence of verapamil and a docking analysis highlighted protein MsbA (Lipid A flippase, gene PA4997) as a potential candidate in novobiocin efflux. MsbA has previously been identified as a multidrug transporter in E. coli, and as P. aeruginosa MsbA presented 76% identity with E. coli MsbA, it is possible that novobiocin efflux involves this ABC transporter, accounting for about 30% of the bacterium resistance to this antibiotic.